Since we demonstrated that TRPV2 is associated with the mesenchymal cell phenotype, the potential contribution of mesenchymal tumor components should not be disregarded when evaluating the role of TRPV2 in cancer. This evidence concerns the gene TRPV2 and neoplasm.